# Safety, Performance of CEREGLIDE 92 Intermediate Catheter in Treatment of Acute Ischemic Stroke

> **NCT06386289** · NA · WITHDRAWN · sponsor: **Cerenovus, Part of DePuy Synthes Products, Inc.**

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DEVICE:** Cereglide 92

## Key facts

- **NCT ID:** NCT06386289
- **Lead sponsor:** Cerenovus, Part of DePuy Synthes Products, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-09-01
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to a change in innovation strategy
- **Last updated:** 2025-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06386289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06386289, "Safety, Performance of CEREGLIDE 92 Intermediate Catheter in Treatment of Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06386289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*